Article Details
Retrieved on: 2021-04-20 12:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
ZURICH (Reuters) - Switzerland's drug regulator is still awaiting data needed to consider AstraZeneca's COVID-19 vaccine candidate for approval, ...
Article found on: whbl.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here